Ypsomed Holding AG (SWX: YPSN)
Switzerland
· Delayed Price · Currency is CHF
364.00
-16.00 (-4.21%)
Nov 15, 2024, 5:31 PM CET
Ypsomed Holding AG Revenue
Ypsomed Holding AG had revenue of 293.07M CHF in the half year ending March 31, 2024, with 20.98% growth. This brings the company's revenue in the last twelve months to 617.07M, up 21.33% year-over-year. In the fiscal year ending March 31, 2024, Ypsomed Holding AG had annual revenue of 548.46M with 10.25% growth.
Revenue (ttm)
617.07M
Revenue Growth
+21.33%
P/S Ratio
7.92
Revenue / Employee
268.76K
Employees
2,296
Market Cap
4.89B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 548.46M | 51.00M | 10.25% |
Mar 31, 2023 | 497.46M | 32.62M | 7.02% |
Mar 31, 2022 | 464.84M | 61.19M | 15.16% |
Mar 31, 2021 | 403.66M | 9.39M | 2.38% |
Mar 31, 2020 | 394.26M | -59.50M | -13.11% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 60.58B |
Roche Holding AG | 60.58B |
Novartis AG | 42.18B |
Lonza Group AG | 6.70B |
Galderma Group AG | 3.88B |
Sonova Holding AG | 3.63B |
Straumann Holding AG | 2.54B |
Galenica AG | 3.80B |